Zivadinov-Robert_hr_88142.jpgROBERT ZIVADINOV, MD, PhD
BNAC Director


Robert Zivadinov, MD, PhD, is a Professor of Neurology at the University of Buffalo, the State University of New York and holds two MD degrees, one from the University of Rijeka in Croatia (1993) and the other from the University of Trieste in Italy (1995). He has also earned two advanced degrees in Neurology, a MSc (1995) and a PhD (2002), both from the University of Rijeka.


Dr. Zivadinov has acquired extensive experience in multiple sclerosis conducting significant and progressive research, and has published more than 350 papers and 650 abstracts. He has received numerous awards from European and national Neurological Societies for his published articles, research studies, and Research Fellowships. In addition, he has served as an MS consultant to several pharmaceutical companies and foundations. Dr. Zivadinov is currently pursuing research studies of quantitative MRI findings in multiple sclerosis and therapeutic interventions, including strategies towards assessing neuroprotective efforts in multiple sclerosis. His current interests also concentrate on the venous function, genetic and neuroepidemiology fields of the same disease. Dr. Zivadinov has contributed chapters to several books and edited his own book on brain and spinal cord atrophy in MS. Currently, he is Director of the Buffalo Neuroimaging Analysis Center (BNAC), part of  the Department of Neurology for the School of Biomedical Sciences at the State University of New York at Buffalo.


Dr. Zivadinov is also the Director, Translational Imaging Center at Clinical Translational Research Center (CTRC); Steering Committee Member, Clinical Translational Research Award at the University at Buffalo. The MRI Center is an entity within the current Center for Biomedical Imaging at the CTRC located on the Buffalo-Niagara Medical Campus in the city of Buffalo, New York that is directed by John M. Canty, MD. The MRI Center hosts two MRI scanners: the 3T Toshiba human MRI and the 9.4T Bruker animal MRI.



Director of Technical Imaging

Michael Dwyer is the Director of Technical Imaging at the Buffalo Neuroimaging Analysis Center (BNAC), and Assistant Professor of Neurology at the University at Buffalo. He is also Director of Computational Analysis at the Center for Biomedical Imaging at the CTRC. He received his PhD in quantitative neuroimaiging analysis methods from the University of Bradford (2013), and also a MSc in Computer Science from Nova Southeastern University (2011). His research as Technical Imaging Director of the Buffalo Neuroimaging Analysis Center focuses on the development and application of quantitative image analysis methods to neuroimaging data in order to better characterize the onset, progression, and treatment of neurological diseases. Specific highlights of his work include the development and validation of a method for detecting and quantifying demyelination and remyelination in vivo, the development of a method dramatically improving on the precision of conventional tissue-specific atrophy measurement, and the creation of a technique for characterization of iron deposition in the basal ganglia. This work has had a substantial impact on our understanding of multiple sclerosis onset and progression, and the first two techniques have been successfully applied in clinical trials to better understand the impact of various therapeutic approaches in multiple sclerosis. His hope is that continuing research into this field can not only drive academic development, but can also be directly translated to clinicians to better inform diagnosis and treatment decisions on an individual patient basis.



Director of MRI Sequence Development/Research Physicist

Dr. Schweser joined BNAC from the Medical Physics Group at Friedrich Schiller University of Jena in Germany where he obtained his Ph.D. Dr. Schweser is an internationally recognized expert in MR phase imaging. His research focuses on understanding MRI contrast mechanisms and improving the specificity and sensitivity of MRI with respect to biophysical properties of the brain. Dr. Schweser has pioneered the development of quantitative susceptibility mapping (QSM), a break-through in quantitative MRI, allowing for unique assessment of iron, calcium and myelin in the brain. He is also Director of MRI Technical Imaging at the Center for Biomedical Imaging at the CTRC. With his extensive background in MRI physics and data processing, Dr. Schweser brings expertise in study design, novel imaging methods, and data post-processing to the MRI center at the CTRC.